 "Glenmark Pharma hits record high")
Shares of Glenmark Pharmaceuticals were trading higher by 2% at Rs 944, extending its previous day’s 4% rally on the BSE, after the company said it has received final nod from the United States Food & Drug Administration (USFDA) for generic oral contraceptive Levonorgestrel/Ethinyl Estradiol tablets and plans to commence shipping of the product immediately.
According to IMS Health sales data for the 12 months to April 2015, the Seasonale brand and all available therapeutic equivalents registered annual sales of around USD 53.7 million, Glenmark said in a release.
The stock opened at Rs 930 and hit a record high of Rs 950 on the BSE. Till 0930 hours, a combined 328,181 shares changed hands on the counter on the NSE and BSE.
According to IMS Health sales data for the 12 months to April 2015, the Seasonale brand and all available therapeutic equivalents registered annual sales of around USD 53.7 million, Glenmark said in a release.
The stock opened at Rs 930 and hit a record high of Rs 950 on the BSE. Till 0930 hours, a combined 328,181 shares changed hands on the counter on the NSE and BSE.